198 related articles for article (PubMed ID: 15243716)
21. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer.
Engelhard K; Hollenbach HP; Wohlfart K; von Imhoff E; Fellner FA
Eur Radiol; 2004 Jan; 14(1):99-105. PubMed ID: 12845463
[TBL] [Abstract][Full Text] [Related]
22. Intraindividual Comparison of
Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
[TBL] [Abstract][Full Text] [Related]
23. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.
Franzius C; Sciuk J; Daldrup-Link HE; Jürgens H; Schober O
Eur J Nucl Med; 2000 Sep; 27(9):1305-11. PubMed ID: 11007511
[TBL] [Abstract][Full Text] [Related]
24. Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review.
Kalus S; Saifuddin A
Eur Radiol; 2019 Oct; 29(10):5700-5708. PubMed ID: 30915559
[TBL] [Abstract][Full Text] [Related]
25. [[Advantages and limitations of whole-body bone marrow MRI using Turbo-STIR sequences in comparison to planar bone scans] ].
Tausig A; Manthey N; Berger F; Sommer H; Pfluger T; Hahn K
Nuklearmedizin; 2000 Sep; 39(6):174-9. PubMed ID: 11057409
[TBL] [Abstract][Full Text] [Related]
26. Detection of malignant bone tumors: MR imaging vs scintigraphy.
Frank JA; Ling A; Patronas NJ; Carrasquillo JA; Horvath K; Hickey AM; Dwyer AJ
AJR Am J Roentgenol; 1990 Nov; 155(5):1043-8. PubMed ID: 2120933
[TBL] [Abstract][Full Text] [Related]
27. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
28. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
29. [A comparison of planar scintigraphy and MRI in the screening of skeletal metastases].
Silit E; Başekim CC; Mutlu H; Pekkafali Z; Kizilkaya E; Karsli AF
Tani Girisim Radyol; 2003 Sep; 9(3):357-61. PubMed ID: 14661604
[TBL] [Abstract][Full Text] [Related]
30. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.
Goo HW; Choi SH; Ghim T; Moon HN; Seo JJ
Pediatr Radiol; 2005 Aug; 35(8):766-73. PubMed ID: 15864576
[TBL] [Abstract][Full Text] [Related]
31. [Nonspecific osteomyelitis in childhood and adolescence. The contribution of imaging diagnosis].
Urso S; Pacciani E; Fariello G; Colajacomo M; Fassari FM; Randisi F; Certo A; Liberatore M; Pagnotta G
Radiol Med; 1995 Sep; 90(3):212-8. PubMed ID: 7501824
[TBL] [Abstract][Full Text] [Related]
32. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
33. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.
Nakanishi K; Kobayashi M; Nakaguchi K; Kyakuno M; Hashimoto N; Onishi H; Maeda N; Nakata S; Kuwabara M; Murakami T; Nakamura H
Magn Reson Med Sci; 2007; 6(3):147-55. PubMed ID: 18037795
[TBL] [Abstract][Full Text] [Related]
34. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer.
Abikhzer G; Srour S; Fried G; Drumea K; Kozlener E; Frenkel A; Israel O; Fogelman I; Kagna O
Nucl Med Commun; 2016 Nov; 37(11):1160-8. PubMed ID: 27536906
[TBL] [Abstract][Full Text] [Related]
35. Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children.
Kellenberger CJ; Miller SF; Khan M; Gilday DL; Weitzman S; Babyn PS
Eur Radiol; 2004 Oct; 14(10):1829-41. PubMed ID: 15365752
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m-MDP scintigraphy and long-term follow-up of treated primary malignant bone tumors.
Van Laere K; Casier K; Uyttendaele D; Mondelaers W; De Sadeleer C; Simons M; Dierckx R
J Nucl Med; 1998 Sep; 39(9):1563-9. PubMed ID: 9744344
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of 18F-FDG PET-directed skeletal biopsy for metastatic neoplasm.
Pezeshk P; Sadow CA; Winalski CS; Lang PK; Ready JE; Carrino JA
Acad Radiol; 2006 Aug; 13(8):1011-5. PubMed ID: 16843854
[TBL] [Abstract][Full Text] [Related]
38. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
[TBL] [Abstract][Full Text] [Related]
39. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
40. SPECT-CT for characterization of extraosseous uptake of 99mTc-methylene diphosphonate on bone scintigraphy.
Soundararajan R; Naswa N; Sharma P; Karunanithi S; Nazar AH; Das KJ; Bal C; Malhotra A; Kumar R
Diagn Interv Radiol; 2013; 19(5):405-10. PubMed ID: 23748034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
